We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,317 hedge funds and large institutions have $291B invested in Johnson & Johnson in 2021 Q1 according to their latest regulatory filings, with 165 funds opening new positions, 1,645 increasing their positions, 1,210 reducing their positions, and 77 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 165 | Existing positions closed: 77

36% more repeat investments, than reductions

Existing positions increased: 1,645 | Existing positions reduced: 1,210

17% more call options, than puts

Call options by funds: $2.69B | Put options by funds: $2.3B

2% more funds holding

Funds holding: 3,2663,317 (+51)

3% more capital invested

Capital invested by funds: $283B → $291B (+$8.05B)

0.63% less ownership

Funds ownership: 68.61%67.97% (-0.63%)

3% less funds holding in top 10

Funds holding in top 10: 557541 (-16)

Holders
3,317
Holders Change
+51
Holders Change %
+1.56%
% of All Funds
58.23%
Holding in Top 10
541
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-2.87%
% of All Funds
9.5%
New
165
Increased
1,645
Reduced
1,210
Closed
77
Calls
$2.69B
Puts
$2.3B
Net Calls
+$395M
Net Calls Change
+$319M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
551
Atria Investments
North Carolina
$23.7M +$774K +4,781 +3%
BSA
552
Braun Stacey Associates
New York
$23.7M -$287K -1,772 -1%
Cetera Investment Advisers
553
Cetera Investment Advisers
Illinois
$23.7M -$726K -4,487 -3%
FGP
554
Foyston, Gordon, & Payne
Ontario, Canada
$23.7M -$1.23M -7,604 -5%
TCOV
555
Trust Company of Vermont
Vermont
$23.6M -$122K -752 -0.5%
SSB
556
Sandy Spring Bank
Maryland
$23.5M -$280K -1,729 -1%
ISL
557
Ingalls & Snyder LLC
New York
$23.4M -$139K -859 -0.6%
CIC
558
Carnegie Investment Counsel
Ohio
$23.3M +$700K +4,329 +3%
NI
559
Nuance Investments
Missouri
$23.1M -$21.9M -135,246 -49%
LCP
560
LGT Capital Partners
Switzerland
$23.1M -$105K -650 -0.5%
PAS
561
Professional Advisory Services
Florida
$23.1M -$1.04M -6,428 -4%
GT
562
Glenview Trust
Kentucky
$22.9M -$1.36M -8,397 -6%
SWP
563
Stratos Wealth Partners
Ohio
$22.9M +$207K +1,280 +0.9%
FNT
564
First National Trust
Pennsylvania
$22.9M -$4.55M -28,104 -17%
VC
565
Veracity Capital
Georgia
$22.8M -$971 -6 -0%
CC
566
Cornerstone Capital
California
$22.7M -$186K -1,151 -0.8%
EW
567
Evoke Wealth
California
$22.7M +$19.6M +121,125 +709%
MIA
568
MainStreet Investment Advisors
Illinois
$22.4M -$1.86M -11,513 -8%
BIM
569
Bridges Investment Management
Nebraska
$22.1M -$2.55M -15,780 -11%
Kovitz Investment Group Partners
570
Kovitz Investment Group Partners
Illinois
$22M +$284K +1,758 +1%
AIA
571
Avalon Investment & Advisory
Texas
$21.9M -$2.31M -14,290 -10%
CCMIC
572
Cardinal Capital Management Inc (Canada)
Manitoba, Canada
$21.9M +$392K +2,420 +2%
MIM
573
Manitou Investment Management
Ontario, Canada
$21.8M -$396K -2,450 -2%
HR
574
Howe & Rusling
New York
$21.7M -$799K -4,937 -4%
QI
575
QV Investors
Alberta, Canada
$21.6M -$1.46M -9,040 -6%

JNJ Hedge Fund Activity: Q1 2021 in Review

3,317 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2021, worth a combined $291B — up 2.8% from $283B a quarter earlier.

Buyers outnumbered sellers: 165 funds opened new JNJ positions and 77 closed out — a net gain of 88 holders — while 1,645 added to existing stakes and 1,210 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $435M. The largest seller was Capital World Investors, cutting an estimated $1.86B.

  • 3,317 institutional investors held Johnson & Johnson (JNJ) as of Q1 2021, up from 3,266 in Q4 2020.
  • Funds reported $291B of Johnson & Johnson stock for Q1 2021, up 2.8% quarter-over-quarter.
  • 165 funds opened new Johnson & Johnson positions in Q1 2021 and 77 closed out, a net change of +88 holders.
  • The largest Johnson & Johnson buyer in Q1 2021 was Arrowstreet Capital, an estimated $435M added.
  • The largest Johnson & Johnson seller in Q1 2021 was Capital World Investors, an estimated $1.86B sold.

Based on aggregated 13F filings for Q1 2021.